The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may prompt Canada to review its approval of the drug.
The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may prompt Canada to review its approval of the drug.